EcoDrugPlus

Integrin Subunit Beta 7

Ensembl ID : ENSLOCG00000007182
Gene Symbol: ITGB7
3 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSLOCG00000011431
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSLOCG00000004844
Gene Symbol: ITGA5
1 Cross references
268 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSLOCG00000001620
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSLOCG00000013350
Gene Symbol: LOC102684715
3 Cross references
25 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSLOCG00000004227
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSLOCG00000014327
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSLOCG00000010646
Gene Symbol: LOC102691398
3 Cross references
262 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSLOCG00000007721
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSLOCG00000014177
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSLOCG00000007077
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLOCG00000007172
Gene Symbol: KIF5B
1 Cross references
281 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).